全文获取类型
收费全文 | 274052篇 |
免费 | 41352篇 |
国内免费 | 10566篇 |
专业分类
耳鼻咽喉 | 6112篇 |
儿科学 | 6841篇 |
妇产科学 | 4682篇 |
基础医学 | 17672篇 |
口腔科学 | 3502篇 |
临床医学 | 42689篇 |
内科学 | 67198篇 |
皮肤病学 | 8773篇 |
神经病学 | 21361篇 |
特种医学 | 10529篇 |
外国民族医学 | 70篇 |
外科学 | 53368篇 |
综合类 | 19208篇 |
现状与发展 | 96篇 |
一般理论 | 5篇 |
预防医学 | 14682篇 |
眼科学 | 6952篇 |
药学 | 13653篇 |
116篇 | |
中国医学 | 6075篇 |
肿瘤学 | 22386篇 |
出版年
2024年 | 1010篇 |
2023年 | 6452篇 |
2022年 | 5826篇 |
2021年 | 8877篇 |
2020年 | 10088篇 |
2019年 | 6134篇 |
2018年 | 11335篇 |
2017年 | 10877篇 |
2016年 | 11684篇 |
2015年 | 13459篇 |
2014年 | 21792篇 |
2013年 | 21476篇 |
2012年 | 14219篇 |
2011年 | 15046篇 |
2010年 | 16121篇 |
2009年 | 18766篇 |
2008年 | 12125篇 |
2007年 | 10370篇 |
2006年 | 12872篇 |
2005年 | 10116篇 |
2004年 | 7369篇 |
2003年 | 6108篇 |
2002年 | 5557篇 |
2001年 | 6991篇 |
2000年 | 6298篇 |
1999年 | 6636篇 |
1998年 | 5868篇 |
1997年 | 5613篇 |
1996年 | 4908篇 |
1995年 | 4652篇 |
1994年 | 3194篇 |
1993年 | 2372篇 |
1992年 | 2587篇 |
1991年 | 2473篇 |
1990年 | 1979篇 |
1989年 | 1993篇 |
1988年 | 1717篇 |
1987年 | 1511篇 |
1986年 | 1389篇 |
1985年 | 1172篇 |
1984年 | 792篇 |
1983年 | 695篇 |
1982年 | 629篇 |
1981年 | 514篇 |
1980年 | 434篇 |
1979年 | 424篇 |
1978年 | 387篇 |
1977年 | 435篇 |
1975年 | 329篇 |
1972年 | 322篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
从产业组织学角度看中国医疗广告 总被引:1,自引:0,他引:1
随着医疗卫生体制改革的全面推行,医疗行业竞争日趋激烈,众多医院采取不同的策略组合以提高其核心竞争力,而广告正是其主要的营销策略之一.本文在对医疗广告特性、类别、作用进行分析的基础上,从产业组织学角度阐述了医疗广告与医疗市场结构、市场效益的关系,提出了中国医疗广告的发展趋势. 相似文献
92.
93.
Controlled release of lidocaine hydrochloride from the surfactant-doped hybrid xerogels. 总被引:2,自引:0,他引:2
We investigate the controlled release of lidocaine hydrochloride from the doped silica-based xerogels. In the xerogel preparation, tetraethoxysilane (TEOS), methyltriethoxysilane (MTES), and propyltriethoxysilane (PTES) are used as precursors, and a nonionic surfactant Igepal CO 720 is used as a dopant. The experimental results suggest that the release of lidocaine hydrochloride can be easily controlled by partially substituting TEOS with the organosilanes, and/or by adding the dopant. Adding the organosilane precursors lowers the release of both the drug and the surfactant in the order of TEOS, MTES/TEOS, and PTES/TEOS xerogels. The release from the PTES/TEOS xerogels is much lower than that from the other xerogels. The release of lidocaine hydrochloride is obviously suppressed by the addition of Igepal CO 720, while the release of Igepal CO 720 is slightly promoted by the addition of the drug. The overall release process is found to be diffusion-controlled, and the release behaviors can be well explained by considering the effects of the textual properties of the xerogels and the interactions among the drug, the surfactant, and the xerogel matrices. 相似文献
94.
Ravinder K. Mittal MD Barry N. Siskind MD Michio Hongo MD M. Wayne Flye MD Richard W. McCallum MD 《Digestive diseases and sciences》1986,31(4):379-384
Three patients with dysphagia caused by compression of the distal esophagus by a tortuous nonaneurysmal atherosclerotic aorta are described. All three patients were elderly women; systemic hypertension and cardiomegaly were present in two patients. Barium studies of the esophagus showed displacement and compression of the distal esophagus by the thoracic aorta. Debilitating dysphagia was treated surgically in one patient. The other two patients had milder symptoms and were managed conservatively. Esophageal manometry in these three patients showed superimposed pulsations and elevated intraluminal pressure just proximal to the lower esophageal sphincter. To evaluate the significance of these manometric findings and their correlation with clinical symptoms, we reviewed manometric tracings in 47 normal subjects. Ten of these subjects had an elevation of baseline intraluminal esophageal pressure as a result of superimposed vascular pulsations. We conclude that (1) compression of the distal esophagus by a tortuous atherosclerotic aorta in the appropriate setting can lead to clinically significant dysphagia and (2) a manometric finding of vascular compression of the esophagus does not necessarily correlate symptomatic dysphagia. 相似文献
95.
对加强药品配送机构监督管理的思考 总被引:1,自引:0,他引:1
国家食品药品监督管理局在《关于全面开展加强农村药品监督网络建设促进农村药品供应网络建设工作的指导意见》中明确指出:“为配合药品配送、连锁进县到乡,各省(区、市)食品药品监督部门可以进行建立区域性药品配送站的研究和指导。在进行研究和探索过程中,鼓励将基层的药品批发企业改组成区域性药品配送站”。 相似文献
96.
Improvement in the Appearance of Wrinkles with Topical Transforming Growth Factor β1 and l-Ascorbic Acid 总被引:1,自引:0,他引:1
MICHELLE EHRLICH MD JAGGI RAO MD ANJU PABBY MD MITCHEL P. GOLDMAN MD 《Dermatologic surgery》2006,32(5):618-625
BACKGROUND AND OBJECTIVE: Facial rhytides are a common cosmetic concern. Surgical treatment effects dramatic improvement; however, the associated risk and cost may be prohibitive. Recent focus is on developing topical products containing biologically active ingredients for at-home therapy. Our study examines the effects of a topical cream containing transforming growth factor-beta(1) (TGF-beta(1)), l-ascorbic acid, and Cimicifuga racemosa extract (CRS) (Topix Pharmaceuticals, North Amityville, NY, USA). MATERIALS AND METHODS: In the first arm of the study, 12 subjects were randomized to apply CRS to the left or right side of their face and a cream containing l-ascorbic acid and C. racemosa in silicone base (vitamin C [Vit C]) to the contralateral side twice daily for 3 months. In the second arm of the study, 20 subjects were randomized to apply CRS to the left or right side of their face and Tissue Nutrient Solution Recovery Complex (TNS) (SkinMedica, Carlsbad, CA, USA), a product containing a variety of growth factors including VEGF, PDGF-A, G-CSF, HGF, IL-6, IL-8, and TGF-beta(1) (Nouricel-MD) without l-ascorbic acid, C. racemosa extract, or silicone base, to the contralateral side of their face twice daily for 3 months. Digital photographs were scored by study-blinded physicians, and self-assessments were completed by all subjects at baseline and at the conclusion of the protocol. RESULTS: CRS and TNS were well tolerated, and all subjects completed the 3-month protocol for the CRS versus Vit C arm of the study. Physicians rated success in facial wrinkling scores on the CRS-treated side of the face for 27 of 31 subjects. Responders showed, on average, 21.7% improvement in physician-rated wrinkle scores. The mean improvement in the group of 31 patients as a whole was 12%. Eighteen of 31 subjects reported a noticeable improvement on their CRS-treated side. Both CRS and TNS demonstrate significant success between baseline and 3-month scores, and both growth factor products are superior to Vit C. Patients preferred CRS over TNS. CONCLUSION: CRS is effective in minimizing the appearance of facial rhytides. The success of the CRS product is largely attributable to the incorporation of TGF-beta(1). 相似文献
97.
98.
99.
100.